New York, NY – July 23, 2025 – Occam Global, a leading international executive search and leadership advisory firm, today released its mid-year 2025 executive hiring report, highlighting key placements and emerging trends in life sciences. As biotech and healthcare sectors rebound with renewed investor interest, the demand for proven, adaptable leadership is intensifying across all stages of company growth.
"In today’s high-stakes biotech environment, investors are looking for more than vision; they are prioritizing resilience," said William Holodnak, Founder & CEO of Occam Global. "Whether it's a CEO, board member, or key C-suite hire, the most investable leaders are those who’ve operated under pressure and learned from failure. A track record matters, but so do adaptability, humility, and the ability to make high-quality decisions in the face of uncertainty.
As a trusted partner in executive recruiting, board development, and leadership advisory, Occam Global continues to deliver elite talent across biotech, technology, and venture capital. The firm is widely recognized for its deep sector expertise, ethical leadership standards, and ability to connect visionary executives with high-impact opportunities.
Notable Executive Placements | 1H 2025
- Paul Burton, MD, PhD | Board, Moonwalk Biosciences
- Angus Sinclair, PhD | Chief Scientific Officer, LabGenius
- Matt Lang | Chief Legal Officer & Corporate Secretary, Metsera
- Bob D. Brown, PhD | Board, Mammoth Biosciences
- Jay Barth, MD | Chief Medical Officer, eGenesis
- McDavid Stilwell | Chief Financial Officer, CPTx
- Michelle Mellion, MD | Chief Medical Officer, EverONE Medicines
- Preetam Shah, PhD | Chief Strategy & Financial Officer, Elicio Therapeutics
- Vidya Vasu Devan | Chief Investment Officer, Global Health Investment Corp.
- Hannah Seitz, PhD | Chief Business Officer, LabGenius
- Laurens Kruidenier, PhD | Chief Scientific Officer, Nilo Therapeutics
- Luke Walker, MD | Chief Medical Officer, Umoja Biopharma
- Emilio Emini, PhD & Lauren Silvernail | Board Members, Dynavax
- Mark Pykett, VMD, PhD | Chief Executive Officer, Orogon Therapeutics
- Purnanand Sarma, PhD | Chief Executive Officer, Aro Biotherapeutics
- Sudhir Rao | Chief Business Officer, Envisagenics
- Michael Bell | Chief Technology Officer, Chemify
- Wanmei Ou, PhD | Vice President, Data Science & Analytics, GSK
- Namandjé Bumpus, PhD & Elaine Sun | Board Members, Recursion
“Boards don’t want perfection; they want pattern recognition. Can this person navigate complex science, shifting markets, and human dynamics, while building trust with investors and teams? That’s the bar now. Capital is no longer just funding platforms, it’s funding people,” stated Holodnak.
With deep expertise in C-suite and board-level searches, Occam Global places CEOs, CFOs,CBOs, COOs, CMOs, CTOs, CPOs, General Counsel, and regulatory leaders in both emerging and established life sciences organizations worldwide. The firm’s leadership team is deeply embedded in the industry and committed to building the next generation of transformative biotech leadership.
About Occam Global
Occam Global isa global executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, TechBio, life sciences, robotics, AI, and venture capital sectors. Trusted by entrepreneurs, investors, and corporations, Occam Global is the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions. To learn more, visit www.occam-global.com.
